Months af­ter re­tir­ing from Genen­tech, Michael Var­ney brings his drug hunt­ing eye to Fra­zier

Michael Var­ney be­gan his post-Genen­tech ca­reer by tak­ing a job as chair­man of R&D at a biotech start­up. Now he’s signed on for a new gig that will put him in di­rect con­tact with a whole lot more.

The biotech vet — who en­joyed a stel­lar rep­u­ta­tion run­ning Roche’s pres­ti­gious gRED or­ga­ni­za­tion in South San Fran­cis­co — is one of two fresh­ly mint­ed life sci­ences se­nior ad­vi­sors at Fra­zier Health­care Part­ners. Pfiz­er vet Don Frail has been tapped for the same role af­ter most re­cent­ly lead­ing the ex­ter­nal sci­ence and in­no­va­tion team at Al­ler­gan.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER